Avicena LVDP Validation Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 406 participants.
Also called NCT05633004
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 406 participants
- Sponsor
- Ventric Health, LLC
- Registry
-
NCT05633004
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT05633004. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-09-27 (actual); primary completion 2022-09-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Avicena LVDP Validation Study
- Condition
- Heart Failure
- Intervention (Device)
- Vivio
- Lead sponsor
- Ventric Health, LLC
Record details
- Record id
cardio:ct-nct05633004- Content hash
1dea17d55a8332ab45da83a09d2ca75361ae0ef6591608d109059861239639c3